TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.85B
AUM Growth
+$177M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
216
New
Increased
Reduced
Closed

Top Buys

1
+$45.7M
2
+$36.7M
3
+$33.8M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$22.1M
5
DXCM icon
DexCom
DXCM
+$20.7M

Top Sells

1
+$44.1M
2
+$40.6M
3
+$39.8M
4
ABBV icon
AbbVie
ABBV
+$27.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$22.7M

Sector Composition

1 Healthcare 95.34%
2 Real Estate 2.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$16.1M 0.56%
96,246
-29,500
52
$15.3M 0.54%
702,523
+61,255
53
$15.2M 0.53%
87,918
-28,927
54
$15.2M 0.53%
117,852
55
$15.1M 0.53%
166,317
-51,145
56
$15M 0.53%
219,995
-168,268
57
$14.5M 0.51%
119,324
+113,647
58
$13.8M 0.48%
122,699
-47,319
59
$13.6M 0.48%
144,525
-7,000
60
$13.6M 0.48%
76,066
-6,200
61
$13.5M 0.47%
97,480
62
$13.3M 0.47%
195,136
+87,135
63
$13.2M 0.46%
152,040
+55,829
64
$13.2M 0.46%
75,198
-6,285
65
$13.1M 0.46%
203,083
66
$13.1M 0.46%
109,659
67
$12.6M 0.44%
271,073
68
$12.4M 0.43%
216,017
69
$12M 0.42%
817,784
+369,735
70
$11.9M 0.42%
37,133
71
$11.7M 0.41%
76,222
72
$11.6M 0.41%
366,176
+271,938
73
$11.3M 0.4%
+56,520
74
$11.2M 0.39%
9,800
75
$11.1M 0.39%
67,456
1 2
3
4 5